NFJ INVESTMENT GROUP, LLC - REPLIGEN CORP ownership

REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 401 filers reported holding REPLIGEN CORP in Q2 2022. The put-call ratio across all filers is 1.20 and the average weighting 0.2%.

Quarter-by-quarter ownership
NFJ INVESTMENT GROUP, LLC ownership history of REPLIGEN CORP
ValueSharesWeighting
Q4 2022$585,982
-95.9%
3,461
-95.4%
0.02%
-96.0%
Q3 2022$14,366,000
-32.4%
75,474
-42.3%
0.38%
-26.2%
Q2 2022$21,254,000
-13.9%
130,874
-0.3%
0.51%
+1.4%
Q1 2022$24,689,000
+72.9%
131,261
+143.4%
0.50%
+92.0%
Q4 2021$14,282,00053,9300.26%
Other shareholders
REPLIGEN CORP shareholders Q2 2022
NameSharesValueWeighting ↓
12 West Capital Management LP 1,021,641$295,244,00013.47%
Ally Bridge Group (NY) LLC 70,000$20,229,0005.95%
Miura Global Management 85,000$24,564,0003.81%
Conestoga Capital Advisors, LLC 871,390$251,823,0003.48%
Ranger Investment Management 187,723$54,250,0002.90%
AWM Investment Company, Inc. 100,000$28,899,0002.84%
Brown Capital Management 1,017,477$294,041,0002.41%
Stephens Investment Management Group LLC 558,287$161,339,0002.19%
Yorktown Management & Research Co Inc 10,050$2,904,0002.18%
SV Health Investors, LLC 14,541$4,203,0002.06%
View complete list of REPLIGEN CORP shareholders